Want to see CH:GALE full AI Analyst Report?
GALE Stock Chart & Stats
CHF86.70
CHF0.45(0.52%)
At close: 4:00 PM EDT
CHF86.70
CHF0.45(0.52%)
Day’s Range― - ―
52-Week RangeCHF80.40 - CHF103.00
Previous CloseN/A
Volume36.68K
Average Volume (3M)91.35K
Market Cap
CHF4.03B
Enterprise ValueCHF5.30K
Total Cash (Recent Filing)CHF39.60M
Total Debt (Recent Filing)CHF1.13B
Price to Earnings (P/E)25.4
Beta0.34
Next Earnings
Mar 09, 2027EPS Estimate
2.1Next Dividend Ex-DateN/A
Dividend Yield3.08%
Share Statistics
EPS (TTM)3.19
Shares Outstanding50,000,000
10 Day Avg. Volume70,861
30 Day Avg. Volume91,351
Financial Highlights & Ratios
PEG Ratio-24.69
Price to Book (P/B)3.29
Price to Sales (P/S)1.18
P/FCF Ratio17.88
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
CHF85.00Price Target Upside-1.96% Downside
Rating ConsensusHold
Number of Analyst Covering1
EPS Forecast (FY)3.78
Revenue Forecast (FY)CHF4.39B
Bulls Say, Bears Say
Bulls Say
Strong Free Cash Flow GenerationConsistent, high free cash flow conversion (FCF ~91% of net income in 2025) underpins durable self‑funding for operations, capex and dividends. Over the next 2–6 months this cash conversion supports financial flexibility and cushions cyclical pressures without immediate reliance on new debt.
Diversified Retail, Wholesale And Services GrowthBroad-based revenue drivers across pharmacies, wholesale and fast‑growing services create durable revenue diversification. Strong retail trends, service adoption (consultations, prescriptions, vaccinations) and acquisitions reduce single-channel risk and support steady organic growth and resilience vs. isolated demand shocks.
Operational Automation And Integration GainsMaterial automation and IT upgrades increase capacity and lower unit costs long term. Site automation and ERP migration should raise throughput and reduce labor intensity and error risk, supporting margin sustainability and scalable growth as retail and logistics volumes expand over multiple quarters.
Bears Say
Rising Leverage And Debt LoadA material increase in leverage reduces balance‑sheet flexibility and raises interest and refinancing sensitivity. Higher debt limits capacity for opportunistic investments or buybacks and magnifies downside risk if earnings slip, making the company more exposed to rate moves and operational volatility.
Working‑capital And FCF VolatilitySeasonal working‑capital swings and timing effects make cash conversion lumpy despite positive FCF. With uneven FCF years and higher debt, the company faces periodic liquidity pressure that can force short‑term financing or constrain capital allocation during slower quarters.
Regulatory And Structural OTC RisksLong‑term regulatory shifts (OTC mail‑order liberalization, fee reductions, lab price cuts, homecare remuneration changes) can structurally alter retail margins and channel mix. Even if gradual, these changes risk reducing high‑margin in‑store sales and require strategic adaptation and potential reinvestment.
Galenica AG News
GALE FAQ
What was Galenica AG’s price range in the past 12 months?
Galenica AG lowest stock price was CHF80.40 and its highest was CHF103.00 in the past 12 months.
What is Galenica AG’s market cap?
Galenica AG’s market cap is CHF4.03B.
When is Galenica AG’s upcoming earnings report date?
Galenica AG’s upcoming earnings report date is Mar 09, 2027 which is in 206 days.
How were Galenica AG’s earnings last quarter?
Galenica AG released its earnings results on Aug 06, 2026. The company reported CHF1.83 earnings per share for the quarter, missing the consensus estimate of CHF1.93 by -CHF0.1.
Is Galenica AG overvalued?
According to Wall Street analysts Galenica AG’s price is currently Overvalued.
Does Galenica AG pay dividends?
Galenica AG pays a Annually dividend of CHF2.5 which represents an annual dividend yield of 3.08%. See more information on Galenica AG dividends here
What is Galenica AG’s EPS estimate?
Galenica AG’s EPS estimate is 2.1.
How many shares outstanding does Galenica AG have?
Galenica AG has 50,000,000 shares outstanding.
What happened to Galenica AG’s price movement after its last earnings report?
Galenica AG reported an EPS of CHF1.83 in its last earnings report, missing expectations of CHF1.93. Following the earnings report the stock price went down -1.063%.
Which hedge fund is a major shareholder of Galenica AG?
Currently, no hedge funds are holding shares in CH:GALE
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Galenica AG
Galenica AG stands as a leading healthcare services company, serving both the Swiss market and international clients. Its operations are organized into two principal divisions: "Products & Care" and "Logistics & IT." The "Products & Care" division oversees an extensive network of 520 pharmacies, comprising 368 directly owned outlets and 152 partner-affiliated pharmacies, operating under the recognized brand names of Amavita, Sun Store, and Coop Vitality. Beyond retail pharmacy services, this segment also provides medication for patients receiving home-based treatment. It is also responsible for the introduction and distribution of a diverse portfolio of consumer health, pharmaceutical, and parapharmaceutical products, in addition to offering vital marketing and sales support to its collaborators within the healthcare sector. The "Logistics & IT" division specializes in offering a suite of pre-wholesale services tailored for pharmaceutical and healthcare enterprises. These services encompass essential functions such as secure storage, efficient distribution, and comprehensive debt collection. Furthermore, this segment provides various logistics and information technology solutions, including a master data system specifically developed for the healthcare industry. It actively creates advanced management solutions relevant to the healthcare market and publishes technical information on pharmaceutical products in both printed and electronic formats, alongside delivering complete management tools for pharmacies. Founded in 1927, Galenica AG maintains its headquarters in Bern, Switzerland.
GALE Stock 12 Month Forecast
Average Price Target
CHF85.00
▼(-1.96% Downside)
Technical Analysis
Bachem Holding AG
―
Medacta Group SA
―
Siegfried Holding AG
―
Tecan Group AG
―
Ypsomed Holding AG
―







